Loading company details...
Beta
Latest Form 4 (Sep 23, 2026): Martin D. Madaus (Interim CEO): Tax Withholding of 1,456 shares, $49.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Martin D. Madaus, Interim CEO | Tax Withholding | 1,456 | $49.9K |
| Sep 17, 2026 | Martin D. Madaus, Interim CEO | Grant/Award | 36,653 | n/a |
| Sep 17, 2026 | William E. Martin III, President Multiomics | Grant/Award | 15,272 | n/a |
| Sep 17, 2026 | Olga Pirogova, SVP and CHRO | Grant/Award | 15,272 | n/a |
| Sep 17, 2026 | Lawrence Y. Lin, EVP, CFO and Treasurer | Grant/Award | 30,544 | n/a |
| Sep 17, 2026 | Ephraim Starr, SVP, Gen Counsel & Secretary | Grant/Award | 15,272 | n/a |
| Sep 17, 2026 | Erik J. Bello, VP Chief Accounting Officer | Grant/Award | 4,586 | n/a |
| Aug 11, 2026 | Olga Pirogova, SVP and CHRO | Tax Withholding | 1,085 | $34.8K |
| Aug 4, 2026 | Ephraim Starr, SVP, Gen Counsel & Secretary | Purchase | 335 | $8.1K |
| May 19, 2026 | William L. Cornog | Purchase | 10,000 | $163.8K |